BNB explores new high-side price zone as treasury announcements roll in

BNB rallied above $850, entering a price discovery zone. The asset responded to its growing list of treasury companies. 

BNB, the native token of BNB Smart Chain, peaked at $858.34, with trading volumes jumping to $3.7B. The token has climbed relentlessly in the past month, starting its rally at around $646. 

The asset got a boost from decentralized trading, but the latest near-vertical climb followed the announcement of a series of treasuries. BNB retains its underlying bullish factors, including a growing user base and increased transaction volumes.

Unlike the unaided BTC and ETH treasuries, the BNB ecosystem gets support from Yzi Labs, Binance’s investment arm. 

The recent BNB price rally followed the announcement of CEA Industries (VAPE), aiming to raise up to $1.25B to buy the token. Liminatus Pharma (LIMN) also revealed plans for a $500M treasury. 

CEA Industries plans to become the biggest public company with a BNB treasury

One of the biggest treasuries announced is the upcoming purchase of CEA Industries (VAPE), a Nasdaq-listed company. The fundraising for the treasury is done with the assistance of 10X Capital, as well as the leadership of Yzi Labs. The PIPE fundraising effort has drawn in 140 subscribers, including Yzi Labs, Pantera Capital, as well as the founders of BitFury.

CEA Industries will raise funds through a Private Investment in Public Equity (PIPE), expecting to raise $400M in cash and $100M in crypto. Up to $750M in cash may be received from exercised warrants. The fundraising efforts for the treasury may depend on both crypto and stock market conditions.

Following the announcement, VAPE shares also went vertical, rising from the $8 range up to a one-year high of $61.63.

VAPE is one more asset to get a second chance from crypto, after losing more than 95% of its value from the peak. VAPE reached an all-time high of $242.64 at a time when the company’s main activity had nothing to do with cryptocurrency. 

Liminatus Pharma intends to raise $500M 

On the same day, Liminatus also stated plans to raise $500M for BNB purchases. The treasury plan was mentioned by Binance’s founder Changpeng “CZ” Zhao. 

One more. https://t.co/dNURuUGOFr

— CZ 🔶 BNB (@cz_binance) July 28, 2025

While high profile, BNB treasuries may still face uncertainties based on market conditions. Treasury announcements may also precede the actual buying by days or even weeks, with no guarantee of increasing demand for the token. 

LIMN shares also rallied by over 58% in a week, even before the treasury announcement. The shares have been trading since May, with no previous signs of involvement in crypto activities. Liminatus Pharma was created as a pre-clinical stage biotechnological company, which aims to boost its portfolio with a rapidly growing token.

“This is not a short-term speculative initiative, but rather a value driven strategy based on the long-term growth potential and strength of the BNB ecosystem,” said Chris Kim, CEO of Liminatus.

Liminatus is also working closely with other ecosystem services, announcing it would use the Ceffu custodial service for its tokens. Unlike other listed companies, Liminatus will retain its core business of searching for new treatments and diagnostic tools while expanding into digital assets with a long-term outlook.  

Over the past week, NanoLabs and Windtree Therapeutics also outlined plans to acquire BNB.

Want your project in front of crypto’s top minds? Feature it in our next industry report, where data meets impact.